HCC updates from ILCA and ESMO congressess 2022

Episode 1 October 06, 2022 00:30:22
HCC updates from ILCA and ESMO congressess 2022
COR2ED Medical Education
HCC updates from ILCA and ESMO congressess 2022

Oct 06 2022 | 00:30:22

/

Show Notes

COR2ED Medical Education: In this HCC CONNECT podcast HCC Experts Prof. Matthias Pinter and Prof. Jeroen Dekervel, discuss and debate the clinical implications of new HCC Phase 3 clinical trials data presented and discussed at the ILCA and ESMO congresses. They discuss Immuno-oncology agents and their place in the upcoming updated guidance such as the proposed new ILCA Systemic Therapies Guidance algorithm. They also discuss new treatment options in first line for advanced HCC presented at ESMO including the three late breaking abstracts LEAP-002, RATIONALE-301 and tislelizumab monotherapy trials. The latter two studying first-line treatment with an anti-PD1 antibody with or without a kinase inhibitor in patients with advanced hepatocellular carcinoma. The experts evaluate and provide their insights into how to integrate these new treatments for HCC in the clinical practice.

Other Episodes

Episode 3

March 27, 2023 00:22:49
Episode Cover

Overview of efficacy and safety data of combination therapy with PARPi and NHAs

Overview of efficacy and safety data of combination therapy with PARPi and NHAs, incorporating the latest data presented and the impact for the treatment...

Listen

Episode 1

September 05, 2022 00:22:19
Episode Cover

Flexible Dosing of Oral Treatments in mCRC

COR2ED Medical Education: In this podcast, Sven De Keersmaecker, RN and Assoc. Prof. Gerald Prager, MD discuss flexible dosing regimens of the oral treatments...

Listen

Episode 25

October 23, 2023 00:23:31
Episode Cover

Treatment of severe PPH – Learnings from clinical practice

COR2ED Medical Education: In this podcast, Prof. Andra H. James (Professor Emeritus of Obstetrics and Gynecology, Division Maternal Fetal Medicine, Duke University Hospital, Durham,...

Listen